Skip to content
Media

Goodbye Needles: The Rise of EMFACE® and the New Under-Eye Innovation

BTL Aesthetics Australia 2 mins read

Under-Eye Bags? EMFACE® Offers a High-Tech, Needle-Free Solution

No Needles, No Downtime: The Latest Under-Eye Treatment Women Are Talking About

If you're looking a little more tired than you feel, you're not alone. For many women, the delicate skin under the eyes is one of the first areas to show signs of stress, sleep deprivation, or time. But for those not keen on injectables or surgery, there’s now a new, non-invasive way to treat this tricky area — and it’s already being offered in clinics across Australia.

Introducing EMFACE® Eye Applicators, a new treatment option developed by BTL Aesthetics to complement the existing EMFACE® system. This latest innovation is designed for use in the periorbital region — the area around the eyes — and is suitable for people seeking a device-based, non-invasive treatment experience.

So what exactly does it do?
EMFACE® uses a combination of HIFES™ (High-Intensity Facial Electrical Stimulation) and Synchronized Radiofrequency (RF) technologies. Together, these work to apply energy to the skin and facial tissues in a way that supports local muscle stimulation and tissue warming. The new Eye Applicators offer a targeted approach for the under-eye area — designed to fit comfortably and work in a session lasting approximately 20 minutes.

According to the team at BTL Aesthetics, qualified health professionals may recommend the treatment for individuals looking to support overall facial skin health, especially in the delicate periorbital area. The technology is TGA-registered(ARTG 393998 and 394105), and sessions are non-invasive with minimal disruption to daily routines — a big plus for busy women.

“People are often looking for options that fit with their lifestyle and overall skin goals,” says Gareth Pepper, Director ANZ at BTL Aesthetics. “This technology has been well received by clinics and patients alike.”

How It Works

  • EMFACE® Eye Applicators are placed under the eyes by a qualified provider.

  • Sessions last around 20 minutes.

  • The system combines electrical stimulation and radiofrequency energy.

  • The goal: to support facial tissue and muscle in a non-invasive way.

Is It Right for You?
If you're exploring options for the under-eye area and prefer a device-based treatment over injectables or surgery, you can speak with a trained provider to see if EMFACE® is suitable for you. You’ll find a list of clinics offering the treatment on the EMFACE Australia directory.

As with all registered medical devices, EMFACE® should only be used by trained healthcare professionals in accordance with the manufacturer’s instructions. Individual results and experiences may vary.


EMFACE® is a registered medical device listed on the Australian Register of Therapeutic Goods (ARTG 393998 and 394105). Treatment should only be provided by qualified healthcare professionals in accordance with the manufacturer’s instructions. Individual experiences may vary.


About us:

Founded in 1993, BTL Aesthetics is a leading innovator in non-invasive medical and aesthetic devices, with products including EMSCULPT NEO®, EXION™, EMSELLA®, and EXILIS ULTRA 360®. Operating in over 80 countries, BTL is committed to developing evidence-based technologies to support body contouring, facial rejuvenation, and intimate health.
🌐 Learn more: btlaesthetics.com.au

 


Contact details:

MEDIA ENQUIRIES
Simone Wyndham | Beauty PR Sydney
📧 [email protected]

HEALTHCARE PROFESSIONAL ENQUIRIES ONLY
Gareth Pepper | BTL Aesthetics Australia
📧 [email protected] | 📞 +61 (0) 435 769 639

Media

More from this category

  • Marketing Advertising, Media
  • 11/12/2025
  • 17:19
Medianet

Low prices, not share prices: New study reveals the media’s impact on consumer trust

Key Facts: A new report from Medianet oncovers key drives of positive sentiment and strong brand reputation on some of Australia’s most trusted brands.…

  • Contains:
  • Media
  • 11/12/2025
  • 00:55
dentsu

The Native Brand, P&G Studios and dentsu Entertainment Launch America’s First Brand Co-Produced Feature-Length “Microsoap” for the Vertical Video Era Produced by Pixie USA, Titled “The Golden Pear Affair”

Trailer and series launch in January 2026; social-first distribution to be followed with a proprietary app experienceLOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Native, a clean beauty and personal care brand, P&G Studios, a division of Procter & Gamble, and dentsu Entertainment, a division of dentsu, today announced the first brand co-produced feature-length “microsoap” in the US. The social-first, short-form scripted series, “The Golden Pear Affair,” produced by Pixie USA, reimagines the classic soap opera for the vertical, mobile-first era. Designed for today’s swipe savvy audiences, the new “microsoap” format delivers fast-paced storytelling with cliff-hangers and character arcs in…

  • Media, Women
  • 10/12/2025
  • 22:12
Faceproof Pty Ltd

With the dangers that come with online dating, gaming, and digital business, Faceproof takes the fear out of every interaction.

Key Facts: https://share.synthesia.io/04917377-3526-4699-8614-ab65bef89acb FOR IMMEDIATE RELEASEDate: 10 December 2025 www.faceproof.ai — https://share.synthesia.io/04917377-3526-4699-8614-ab65bef89acb Brisbane, AU – Today marks the official launch of www.faceproof.ai, a powerful…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.